Philippe Nizard
-
- Cancer Genomics and Diagnostics 4
- Oncology top 10%
- CAR-T cell therapy research 4
-
- Toxin Mechanisms and Immunotoxins 6
- Biotechnology top 10%
- Transgenic Plants and Applications 4
- Cancer Research and Treatments 3
-
- Innovative Microfluidic and Catalytic Techniques Innovation 5
-
- Gold and Silver Nanoparticles Synthesis and Applications 4
-
- Virus-based gene therapy research 3
Philippe Nizard
31 papers receiving 830 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 157
- Oncology 264
- Aging 13
- Immunology 150
- Biotechnology 56
Countries citing papers authored by Philippe Nizard
This map shows the geographic impact of Philippe Nizard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Nizard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Nizard more than expected).
Fields of papers citing papers by Philippe Nizard
This network shows the impact of papers produced by Philippe Nizard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Nizard. The network helps show where Philippe Nizard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philippe Nizard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2020 | 1 | |
| 6 | 2018 | 57 | |
| 7 | 2017 | 19 | |
| 8 | 2017 | 48 | |
| 9 | 2015 | 10 | |
| 10 | 2015 | 11 | |
| 11 | 2015 | 38 | |
| 12 | 2014 | 118 | |
| 13 | 2014 | 4 | |
| 14 | 2007 | 120 | |
| 15 | 2003 | 14 | |
| 16 | 2002 | 64 | |
| 17 | 2002 | 31 | |
| 18 | 2001 | 21 | |
| 19 | 1998 | 13 | |
| 20 | 1998 | 11 |
About Philippe Nizard
Philippe Nizard is a scholar working on Biotechnology, Immunology, Oncology, Biomedical Engineering and Cancer Research, having authored 31 papers that have together received 841 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (6 papers), Innovative Microfluidic and Catalytic Techniques Innovation (5 papers), CAR-T cell therapy research (4 papers), Gold and Silver Nanoparticles Synthesis and Applications (4 papers), Cancer Genomics and Diagnostics (4 papers), Transgenic Plants and Applications (4 papers), Virus-based gene therapy research (3 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Cancer Research (157 citations), Oncology (264 citations), Aging (13 citations), Immunology (150 citations) and Biotechnology (56 citations). Philippe Nizard has collaborated with scholars based in France, Australia and Germany. Frequent co-authors include Valérie Taly, Pascale Le Goff, Denis Michel, Daniel Gillet, Yves Le Dréan, Alexandre Chenal, Laure Debure, Fabien Loison, Ouriel Caën and Eleonora Zonta. Their work appears in journals such as Protein Engineering Design and Selection, Scientific Reports, Molecular Therapy, Clinical Cancer Research and Traffic.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.